María G Otero
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
María G Otero has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Carlos M. Guardia
National Institutes of Health
1 shared publication - Christina Freeman
Cedars-Sinai Medical Center Board of Governors Regenerative Medicine Institute Los Angeles, CA 90048 , USA
1 shared publication - Juan S. Bonifacino
Division of Neuroscience and Cellular Structure, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA
1 shared publication - Morié Ishida
Eunice Kennedy Shiver National Institute of Child Health and Human Development, National Institutes of Health Neurosciences and Cellular and Structural Biology Division Bethesda, MD 20892 , USA
1 shared publication - Pedro A. Sanchez-Lara
Pediatrics and Medical Genetics, Cedars-Sinai Medical Center, Los Angeles, USA
1 shared publication - Tyler Mark Pierson
Department of Pediatrics, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
1 shared publication
Latest Publications
- Open Access
- 8 November 2022
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 32 (7) , 1162-1174
A neurodevelopmental disorder associated with an activatingde novomissense variant inARF1
ADP-ribosylation factor 1 (ARF1) is a small GTPase that regulates membrane traffic at the Golgi apparatus and endosomes through recruitment of several coat proteins and lipid-modifying enzymes. Here, we report a pediatric patient with an ARF1-related disorder because of a monoallelic de novo missense variant (c.296 G > A; p.R99H) in the ARF1 gene, associated with developmental delay, hypotonia, intellectual disability and motor stereotypies. Neuroimaging revealed a hypoplastic corpus callosum and subcortical white matter abnormalities. Notably, this patient did not exhibit periventricular heterotopias previously observed in other patients with ARF1 variants (including p.R99H). Functional analysis of the R99H-ARF1 variant protein revealed that it was expressed at normal levels and properly localized to the Golgi apparatus; however, the expression of this variant caused swelling of the Golgi apparatus, increased the recruitment of coat proteins such as coat protein complex I, adaptor protein complex 1 and GGA3 and altered the morphology of recycling endosomes. In addition, we observed that the expression of R99H-ARF1 prevented dispersal of the Golgi apparatus by the ARF1-inhibitor brefeldin A. Finally, protein interaction analyses showed that R99H-ARF1 bound more tightly to the ARF1-effector GGA3 relative to wild-type ARF1. These properties were similar to those of the well-characterized constitutively active Q71L-ARF1 mutant, indicating that the pathogenetic mechanism of the R99H-ARF1 variant involves constitutive activation with resultant Golgi and endosomal alterations. The absence of periventricular nodular heterotopias in this R99H-ARF1 subject also indicates that this finding may not be a consistent phenotypic expression of all ARF1-related disorders.
- 8 November 2022
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 32 (7) , 1162-1174
Open AccessA neurodevelopmental disorder associated with an activatingde novomissense variant inARF1
ADP-ribosylation factor 1 (ARF1) is a small GTPase that regulates membrane traffic at the Golgi apparatus and endosomes through recruitment of several coat proteins and lipid-modifying enzymes. Here, we report a pediatric patient with an ARF1-related disorder because of a monoallelic de novo missense variant (c.296 G > A; p.R99H) in the ARF1 gene, associated with developmental delay, hypotonia, intellectual disability and motor stereotypies. Neuroimaging revealed a hypoplastic corpus callosum and subcortical white matter abnormalities. Notably, this patient did not exhibit periventricular heterotopias previously observed in other patients with ARF1 variants (including p.R99H). Functional analysis of the R99H-ARF1 variant protein revealed that it was expressed at normal levels and properly localized to the Golgi apparatus; however, the expression of this variant caused swelling of the Golgi apparatus, increased the recruitment of coat proteins such as coat protein complex I, adaptor protein complex 1 and GGA3 and altered the morphology of recycling endosomes. In addition, we observed that the expression of R99H-ARF1 prevented dispersal of the Golgi apparatus by the ARF1-inhibitor brefeldin A. Finally, protein interaction analyses showed that R99H-ARF1 bound more tightly to the ARF1-effector GGA3 relative to wild-type ARF1. These properties were similar to those of the well-characterized constitutively active Q71L-ARF1 mutant, indicating that the pathogenetic mechanism of the R99H-ARF1 variant involves constitutive activation with resultant Golgi and endosomal alterations. The absence of periventricular nodular heterotopias in this R99H-ARF1 subject also indicates that this finding may not be a consistent phenotypic expression of all ARF1-related disorders.